Patent details

Basic Information

Publication number:

EP1417231

PCT Application Number:

PCT/US/2002/023475

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP027937614

PCT Publication Number:

WO/2003/032898

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

MODIFIED HUMAN THYMIC STROMAL LYMPHOPOIETIN

French Title of Invention:

LYMPHOPOIETINE THYMIQUE STROMALE (TSLP) HUMAINE MODIFIEE

German Title of Invention:

MODIFIZIERTES HUMANES THYMISCHES STROMA-LYMPHOPOIETIN

SPC Number:

Dates

Filing date:

23/07/2002

Grant date:

19/06/2013

EP Publication Date:

19/06/2013

PCT Publication Date:

24/04/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/05/2004

EP B1 Publication Date:

19/06/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

23/07/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/07/2002

 

 

Name:

Immunex Corporation

Address:

One Amgen Center Drive, Thousand Oaks, CA 91320-1799, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

17/07/2013

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

PAXTON Raymond, J.

Address:

United States (US)

2

Name:

VAN NESS Kirk, P.

Address:

United States (US)

3

Name:

LYMAN Stewart, D.

Address:

United States (US)

Priority

Priority Number:

307345 P

Priority Date:

23/07/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

C07K 14/54;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

12/07/2021

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages